Surgical resection of lung adenocarcinoma without EGFR mutation after neoadjuvant gefitinib treatment
Author:
Publisher
Wiley
Subject
Genetics (clinical),Pulmonary and Respiratory Medicine,Immunology and Allergy
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1752-699X.2009.00167.x/fullpdf
Reference4 articles.
1. Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naïve non-small-cell lung cancer receiving first-line gefitinib monotherapy;Yang;J Clin Oncol.,2008
2. Multicentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Oncology Group trial (WJTOG0403);Tamura;Br J Cancer,2008
3. EGFR mutation of tumor and serum in gefitinib-treated patients with chemotherapy-naive non-small cell lung cancer;Kimura;J Thorac Oncol.,2006
4. Surgical resection after gefitinib treatment in patients with lung adenocarcinoma harboring epidermal growth factor receptor gene mutation;Takamochi;Lung Cancer.,2007
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Rescue Surgery after Immunotherapy/Tyrosine Kinase Inhibitors for Initially Unresectable Lung Cancer;Cancers;2022-05-27
2. Impact of preoperative targeted therapy duration on survival in patients with distant primary site and Stage III-IV non-small cell lung cancer in the presence of mutations in the EGFR gene;Onkologiya. Zhurnal imeni P.A.Gertsena;2022
3. Pathological Complete Response after Immune-Checkpoint Inhibitor Followed by Salvage Surgery for Clinical Stage IV Pulmonary Adenocarcinoma with Continuous Low Neutrophil-to-Lymphocyte Ratio: A Case Report;Case Reports in Oncology;2021-07-19
4. Salvage surgery for non-small cell lung cancer after tyrosine kinase inhibitor treatment;Lung Cancer;2021-03
5. Role of surgical treatment in patients with EGFR mutation-positive locally advanced and disseminated non-small-cell lung cancer;Onkologiya. Zhurnal imeni P.A.Gertsena;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3